Depression and Anxiety Trial, Recruiting (NCT06609824)

Depression and Anxiety Trial, Recruiting NCT06609824 Sponsor: Leiden University Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT06609824 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children or young people who score at or above a certain level on an anxiety screening tool called the SCARED (the required score is 31 or higher for girls, and 27 or higher for boys)

Who may not be able to join:

People who are currently receiving treatment for anxiety, or who are currently receiving any mental health treatment for other emotional or mood-related difficulties
People whose anxiety or related difficulties are considered serious enough to need professional treatment, including those who score 6 or higher on a clinical severity rating scale (called the CSR, part of the ADIS), or those who score above the clinical cut-off on a depression measure called the Child Depression Inventory
People who would have difficulty understanding or following the training involved in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anke M Klein, AS, Leiden University

Phone: +31655111908

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06609824

Sponsor: Leiden University

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: +31655111908

More information: https://clinicaltrials.gov/study/NCT06609824

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children or young people who score at or above a certain level on an anxiety screening tool called the SCARED (the required score is 31 or higher for girls, and 27 or higher for boys)

Who may not be able to join:

People who are currently receiving treatment for anxiety, or who are currently receiving any mental health treatment for other emotional or mood-related difficulties
People whose anxiety or related difficulties are considered serious enough to need professional treatment, including those who score 6 or higher on a clinical severity rating scale (called the CSR, part of the ADIS), or those who score above the clinical cut-off on a depression measure called the Child Depression Inventory
People who would have difficulty understanding or following the training involved in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Leiden University

Registry

ClinicalTrials.gov

Start date

2 April 2024

Est. completion

31 December 2028

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Change in anxiety severity in children (SCARED-child); Change in anxiety severity in children (SCARED-parent); Change in severity of anxiety in children (SCID-parent); Change in severity of anxiety in children (SCID-child)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov